MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278.
Our nationally recognized nephrology program is led by physicians whose of expertise is unmatched in the region and whose commitment to scientific research means patients have access to emerging kidney disease therapies not widely available.
The University of Chicago Medicine is a recognized leader in the field of nephrology.
Our multidisciplinary program in Hyde Park offers a convenient, one-stop experience for kidney patients who often require visits with multiple clinicians. By streamlining referrals to other specialists, including transplant surgeons, endocrinologists, cardiologists and dietitians, you can have several consultations on the same day as your nephrology visit.
We offer a robust dialysis program — including at-home, nighttime, hemo and peritoneal dialysis options. Importantly, kidney transplants are performed and managed by some of the most experienced surgeons and transplant nephrologists in the state.
We are the largest referral center for polycystic kidney disease (PKD) throughout Illinois and the Great Lakes region, having evaluated and managed care for more than 2,000 patients.
Our kidney stone management program was established in 1969. Nearly 50 years – and more than 7,000 patients – later, the program has become an internationally recognized treatment and research center for people with kidney stones.
Our kidney transplant center is one of the most active programs in the state, with patient survival rates that continually exceed national averages. We’re also one of the few hospitals in the country qualified to perform kidney-pancreas and experimental islet cell transplants for patients with type 1 diabetes, as well as combined liver-kidney and heart-kidney transplants.
UChicago Medicine physicians and researchers are dedicated to research in order to find new options that offer our kidney patients an improved quality of life.
Our clinical research programs include NIH-funded research in autosomal dominant polycystic kidney disease (ADPKD), kidney stones, acute kidney injury, hypertension, vitamin D metabolism, metabolic bone disease, renal imaging and vascular physiology, as well as industry-sponsored work in end stage renal disease (ESRD), anemia management in chronic kidney disease and ESRD and transplantation.
Through our clinical trials, we also offer you access to the newest treatments that are not yet widely available on the market.